Enact (ACT) vs CorVel (CRVL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Enact (ACT) has outperformed CorVel (CRVL) over the past year, gaining 27.6% versus a gain of 3.2%. Over five years, ACT leads with a +112.5% price change compared with +31.4% for CRVL. Enact is the larger company by market cap ($6.41 billion vs $3.86 billion), about 1.7 times the size, while CorVel is growing revenue faster (+7.0% vs +2.8%).
On valuation, Enact trades at a lower trailing P/E (9.8x vs 34.1x for CorVel). Enact pays a dividend yielding 1.87%, while CorVel does not currently pay one. Enact converts more of its revenue into profit, with a net margin of 54.6% versus 11.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACT | CRVL |
|---|---|---|
| Share price | $46.64 | $76.35 |
| Market cap | $6.41B | $3.86B |
| 1-day change | +1.79% | -0.18% |
| YTD return | +15.59% | +13.03% |
| 1-year return | +27.60% | +3.21% |
| 5-year return | +112.52% | +31.37% |
| P/E ratio (TTM) | 9.84 | 34.08 |
| Forward P/E | 9.23 | — |
| EPS (TTM) | $4.74 | $2.24 |
| Dividend yield | 1.87% | 0.00% |
| Annual dividend | $0.87 | $0.00 |
| Revenue (latest FY) | $1.24B | $958.53M |
| Revenue growth (YoY) | +2.83% | +7.03% |
| Net income (latest FY) | $674.24M | $110.34M |
| Gross margin | — | 24.29% |
| Net margin | 54.56% | 11.51% |
| 52-week high | $50.56 | $79.43 |
| 52-week low | $34.64 | $44.83 |
| Distance from 52-week high | -7.75% | -3.88% |
| Analyst consensus | none | — |
| Avg. price target upside | +7.63% | — |
| Average volume | 394.00K | 189.30K |
| Shares outstanding | 137.48M | 50.52M |
| Employees | 419 | 5,239 |
| Sector | Finance | Finance |
| Industry | Specialty Insurers | Specialty Insurers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACT has outperformed CRVL by 24.4 percentage points over the past year.
- CorVel trades at a higher earnings multiple (34.1x vs 9.8x trailing P/E).
- Enact offers a meaningfully higher dividend yield (1.87% vs 0.00%).
- Enact is more profitable, keeping 54.6 cents of every revenue dollar as net income versus 11.5 cents for CorVel.
About Enact
ACT stock →Enact Holdings, Inc. operates as a private mortgage insurance company in the United States.
Finance · Specialty Insurers · 419 employees
About CorVel
CRVL stock →CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Finance · Specialty Insurers · 5,239 employees
ACT vs CRVL FAQ
Which is bigger, Enact or CorVel?
Enact (ACT) is larger, with a market capitalization of $6.41B compared with $3.86B for CorVel (CRVL).
Which stock has performed better over the past year, ACT or CRVL?
ACT returned +27.60% over the past 12 months, compared with +3.21% for CRVL (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ACT or CRVL?
ACT has the lower trailing P/E at 9.8, versus 34.1 for CRVL. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Enact or CorVel?
Enact pays a dividend yielding 1.87%, while CorVel does not currently pay a regular dividend.
Are Enact and CorVel in the same industry?
Yes. Both are classified in the Specialty Insurers industry within the Finance sector.